Key result
Team-based collaborative care trial evaluates quality of life improvements in distressed CHD patients.
Why the study?
There are unmet needs for interventions supporting secondary prevention health behaviors in CHD, where psychosocial distress is common and linked to reduced HRQoL, poor health behavior, and low treatment adherence.
Does 12-months of blended collaborative care improve health-related quality of life in distressed patients with chronic coronary heart disease?
RCT (n=440)
Observer blind
1:1 ratio stratified by study site based on permuted blocks
Yes
Does 12-months of blended collaborative care improve health-related quality of life in distressed patients with chronic coronary heart disease?
The TEACH trial protocol describes a randomized study to evaluate a blended collaborative care intervention for improving quality of life and risk factors in distressed patients with chronic coronary heart disease.
Answers are grounded in this paper and cite their sources.
Blended collaborative care should not yet alter practice in distressed CHD; TEACH RCT will test HRQoL benefit in 440 patients.
BACKGROUND: Coronary heart disease (CHD) is the leading cause of death and years of life lost worldwide. While effective treatments are available for both acute and chronic disease stages there are unmet needs for effective interventions to support patients in health behaviors required for secondary prevention. Psychosocial distress is a common comorbidity in patients with CHD and associated with substantially reduced health-related quality of life (HRQoL), poor health behavior, and low treatment adherence. METHODS: In a confirmatory, randomized, controlled, two-arm parallel group, multicenter behavioral intervention trial we will randomize 440 distressed CHD patients with at least one insufficiently controlled cardiac risk factor to either their physicians' usual care (UC) or UC plus 12-months of blended collaborative care (TeamCare = TC). Trained nurse care managers (NCM) will proactively support patients to identify individual sources of distress and risk behaviors, establish a stepwise treatment plan to improve self-help and healthy behavior, and actively monitor adherence and progress. Additional e-health resources are available to patients and their families. Intervention fidelity is ensured by a treatment manual, an electronic patient registry, and a specialist team regularly supervising NCM via videoconferences and recommending protocol and guideline-compliant treatment adjustments as indicated. Recommendations will be shared with patients and their physicians who remain in charge of patients' care. Since HRQoL is a recommended outcome by both, several guidelines and patient preference we chose a ≥ 50% improvement over baseline on the HeartQoL questionnaire at 12 months as primary outcome. Our primary hypothesis is that significantly more patients receiving TC will meet the primary outcome criterion compared to the UC group. Secondary hypotheses will evaluate improvements in risk factors, psychosocial variables, health care utilization, and durability of intervention effects over 18-30 months of follow-up. DISCUSSION: TEACH is the first study of a blended collaborative care intervention simultaneously addressing distress and medical CHD risk factors conducted in cardiac patients in a European health care setting. If proven effective, its results can improve long-term chronic care of this vulnerable patient group and may be adapted for patients with other chronic conditions. TRIAL REGISTRATION: German Clinical Trials Register, DRKS00020824, registered on 4 June, 2020; https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00020824.
No takes yet. Share an insight, caveat, or question.
Herrmann‐Lingen et al. (2020) conducted an RCT in Chronic coronary heart disease with psychosocial distress (n=440). Team-based collaborative care (TeamCare) vs. Physicians' usual care was evaluated on ≥ 50% improvement over baseline on the HeartQoL questionnaire at 12 months. Team-based collaborative care will be evaluated in a randomized controlled trial of 440 distressed patients with coronary heart disease to determine if it improves health-related quality of life.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: